Coya Therapeutics, Inc. Common Stock (COYA) financials · rev $7.9M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Coya Therapeutics, Inc. Common Stock (COYA) rev $7.9M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $7.95M | $3.55M |
| Operating Income | -$22.6M | -$17.2M |
| Net Income | -$21.2M | -$14.9M |
| EPS (Diluted) | -$1.27 | -$0.98 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $50.0M | $44.3M |
| Current Assets | $49.9M | $44.3M |
| Cash & Equivalents | $46.8M | $38.3M |
| PP&E | $11.2K | $38.6K |
| Total Liabilities | $6.92M | $4.77M |
| Current Liabilities | $5.87M | $3.82M |
| Shareholders' Equity | $43.0M | $39.6M |
| Retained Earnings | -$62.0M | -$40.7M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$10.7M | -$10.3M |
| Investing Cash Flow | -$1.16M | -$25.0K |
| Financing Cash Flow | $20.4M | $16.0M |
FAQ
What is COYA P/E and revenue?
Coya Therapeutics, Inc. Common Stock (COYA) rev $7.9M.
What is COYA revenue?
Coya Therapeutics, Inc. Common Stock last cached revenue is $7.95M (FY2025).
Is COYA profitable?
Coya Therapeutics, Inc. Common Stock last cached net income is -$21.2M (FY2025).
What are COYA total assets?
Coya Therapeutics, Inc. Common Stock last cached total assets are $50.0M (FY2025).
What is COYA free cash flow?
No cached cash-flow row for COYA yet.
Not investment advice. Cached statements, not a live tape.